Treatment for Anxiety Disorders

Phase-Based Estimates
Michael E. DeBakey VA Medical Center, Houston, TX, Houston, TX
Anxiety Disorders
All Sexes
Eligible conditions
Anxiety Disorders

Study Summary

This study is evaluating whether a new form of cognitive behavioral therapy may help improve the quality of life for veterans with anxiety disorders.

See full description

Treatment Effectiveness

Study Objectives

This trial is evaluating whether Treatment will improve 2 primary outcomes and 2 secondary outcomes in patients with Anxiety Disorders. Measurement will happen over the course of 6-month follow-up.

6-month follow-up
Change from Baseline Beck Anxiety Inventory (BAI) at 6 month follow-up
Change from Baseline Beck Depression Inventory - Second Edition (BDI-II) at 6 month follow-up
Change from Baseline Community Reintegration of Injured Service Members (CRIS) at 6 month follow-up
Change from Baseline Short Form -12 Health Survey (SF-12) at 6 month follow-up

Trial Safety

Safety Estimate

2 of 3
This is better than 68% of similar trials

Trial Design

2 Treatment Groups


This trial requires 265 total participants across 2 different treatment groups

This trial involves 2 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are in Phase 2 & 3 and have had some early promising results.

Patients in this arm will receive transdiagnostic CBT delivered in an intensive format over one weekend.
Patients in this arm will receive transdiagnostic CBT delivered in a standard weekly format for 12 weeks.

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6-month follow-up
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly 6-month follow-up for reporting.

Closest Location

Michael E. DeBakey VA Medical Center, Houston, TX - Houston, TX

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 5 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
Veterans enrolled to receive VA medical care
Current diagnosis of at least one anxiety-based disorder
Moderate-to-poor life enjoyment and satisfaction
Stable on psychotropic medication 4 weeks prior to participation
Willing to be randomized to treatment condition

Patient Q&A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for Anxiety Disorders by sharing your contact details with the study coordinator.